The invention relates to racemic or enantiomerically pure 4-pyrrolidino derivatives, processes for their preparation, pharmaceutical compositions comprising said derivatives, and their use in the prevention and treatment of illness, in particular which is mediated by monoamine oxidase B inhibitors, in particular Alzheimer's disease or senile dementia.

 
Web www.patentalert.com

< Pyrido [2,1-a] isoquinoline derivatives

< Sulfonyl-amidino-containing and tetrahydropyrimidino-containing compounds as factor Xa inhibitors

> Biaromatic ligand activators of PPAR.gamma. receptors

> Heterocyclic amide derivatives having glycogen phosphorylase inhibitory activity
~ 00295